Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of EU Stress Test Exercise

23 Jul 2010 17:51

RNS Number : 8765P
Royal Bank of Scotland Group PLC
23 July 2010
 



The Royal Bank of Scotland Group PLC - Results of EU stress test exercise

23 July 2010

 

The Royal Bank of Scotland Group plc ("RBS") welcomes the publication of the results of the EU-wide stress testing exercise and confirms it remains well capitalised with a strong Tier One capital ratio under both the benchmark and adverse scenarios. It is important to note that the tests are theoretical in nature and none of the data published represent a forecast or prediction by RBS of what would actually happen in any of the modelled scenarios. Furthermore, the results are FSA calculations impacting revenues, impairments and balance sheet items and assume an unchanged balance sheet from end 2009.

 

RBS has continued to make good progress in its restructuring plans including the de-risking of its balance sheet, and reaffirms its commitment to strong capital ratios. It regularly runs its own stress tests to ensure capital adequacy. RBS will report its interim results for 2010 on Friday, 6 August.

 

Bruce Van Saun, Group Finance Director for RBS said: "We support the need for banks to maintain strong capital ratios and we believe that stress tests like these, whilst theoretical, can provide insights into absolute and relative strength. We are pleased that the results demonstrate the strong capital position of RBS as we endeavour to execute our recovery plans over the coming years."

 

The results for RBS are summarised in the table below with further detail in Appendix One.

 

 

2009

Benchmark 2011

Adverse 2011

All figures GBPm

Before additional Sovereign Risk Scenario

After Additional Sovereign Risk Scenario

 

 

 

 

 

Total tier 1 capital

62,898

63,460

54,644

 

Total regulatory capital

71,320

71,789

62,849

 

 

 

 

 

 

Total Risk Weighted Assets

438,200

450,029

468,525

 

 

 

 

 

 

Pre-impairment income (including operating expenses)(1),(2)

7,667

 

24,219

 

 

 

 

 

 

Impairments on financial assets(2)

 

 

(27,355)

 

Trading losses(2)

 

 

(3,543)

 

Additional impairment losses (sovereign scenario banking book)(2)

 

 

 

(1,064)

Additional valuation losses (sovereign scenario trading book)(2)

 

 

 

(1,809)

 

 

 

 

 

Tier 1 ratio(3)

14.4%

14.1%

11.7%

11.2%

 

 

 

 

 

(1) The 2009 pre-impairment income number includes credit and other market losses of £6,152m reported in Income From Trading Activities. However, the 2011 benchmark and adverse stress scenarios exclude trading losses from pre-impairment income.

(2) The numbers for pre-impairment income, impairments and trading losses shown in the adverse scenarios are cumulative for 2010 and 2011 combined and are FSA scenarios not RBS forecasts.

(3) Note that under the assumptions used for both the benchmark and adverse scenarios shown above, RBS has not needed to draw on its £8bn contingent capital facility (equivalent to c. 1.8% of Tier 1 capital ratio in addition to the ratios shown above as at the end of 2009) nor receive any net payments under the Asset Protection Scheme through the end of 2011, representing additional capital strength.

 

Appendix Two shows our gross and net consolidated exposures to central and local governments in the thirty European Economic Area countries as at 31 March 2010. RBS continued to reduce exposures to countries with credit ratings of A+ or below during the second quarter of 2010.

 

Further details of the stress tests and the assumptions behind them along with further explanatory notes can be found on the websites of the Committee of European Banking Supervisors ("CEBS") at www.c-ebs.org/ and the UK Financial Services Authority ("FSA") at www.fsa.gov.uk. As both the FSA and CEBS emphasise in their communications, these simulations are not profit forecasts and should in no way be construed as such.

 

For Further Information Contact:

 

Richard O'Connor

Investor Relations 

+44 (0) 20 7672 1758 

 

Group Media Centre

Tel: +44 (0) 131 523 4205

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS's regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business plans and strategies, and are based upon the Group's current expectations. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or the Group's actual results are discussed in RBS's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

Appendix One - Results of CEBS stress tests for RBS

 

Actual results

At 31 December 2009

GBPm

Total Tier 1 capital

62,898

Total regulatory capital

71,320

Total risk weighted assets

438,200

Pre-impairment income (including operating expenses)

7,667

Impairment losses on financial assets in the banking book

(13,899)

1 yr Loss rate on Corporate exposures (%)(1)

2.2%

1 yr Loss rate on Retail exposures (%)(1)

1.6%

Tier 1 ratio (%)

14.4%

Outcomes of stress test scenarios

The stress test was carried out under a number of key common simplifying assumptions (e.g. constant balance sheet, uniform treatment of securitisation exposures). Therefore, the information relative to the benchmark scenarios is provided only for comparison purposes. Neither the benchmark scenario nor the adverse scenario should in any way be construed as a forecast.

Benchmark scenario at 31 December 2011(2)

GBPm

Total Tier 1 capital after the benchmark scenario

63,460

Total regulatory capital after the benchmark scenario

71,789

Total risk weighted assets after the benchmark scenario

450,029

Tier 1 ratio (%) after the benchmark scenario

14.1%

Adverse scenario at 31 December 2011(2)

GBPm

Total Tier 1 capital after the adverse scenario

54,644

Total regulatory capital after the adverse scenario

62,849

Total risk weighted assets after the adverse scenario

468,525

2 yr cumulative pre-impairment income after the adverse scenario (including operating expenses)(2)

24,219

2 yr cumulative impairment losses on financial assets in the banking book after the adverse scenario(2)

(27,355)

2 yr cumulative losses on the trading book after the adverse scenario(2)

(3,543)

2 yr Loss rate on Corporate exposures (%) after the adverse scenario(1),(2)

3.0%

2 yr Loss rate on Retail exposures (%) after the adverse scenario(1),(2)

4.6%

Tier 1 ratio (%) after the adverse scenario

11.7%

 

Additional sovereign shock on the adverse scenario at 31 December 2011

GBPm

Additional impairment losses on the banking book after the sovereign shock(2)

(1,064)

Additional losses on sovereign exposures in the trading book after the sovereign shock(2)

(1,809)

2 yr Loss rate on Corporate exposures (%) after the adverse scenario and sovereign shock(1),(2),(3)

3.2%

2 yr Loss rate on Retail exposures (%) after the adverse scenario and sovereign shock(1),(2),(3)

4.8%

Tier 1 ratio (%) after the adverse scenario and sovereign shock

11.2%

Additional capital needed to reach a 6 % Tier 1 ratio under the adverse scenario + additional sovereign shock, at the end of 2011

-

(1) Impairment losses as a % of corporate/retail exposures in Available for sale ('AFS') and loans and receivables portfolios.

(2) Cumulative for 2010 and 2011.

(3) On the basis of losses estimated under both the adverse scenario and the additional sovereign shock.

Appendix Two - Exposures to central and local governments

 

All figures in GBPm

Gross exposures (net of impairments)

Of which Banking book

Of which Trading Book

 

Net exposures (net of impairments)

 

 

 

 

 

 

Austria

229

222

7

 

229

Belgium

1,977

1,169

808

 

1,977

Bulgaria

-

-

-

 

-

Cyprus

-

-

-

 

-

Czech Republic

169

169

-

 

169

Denmark

619

608

11

 

619

Estonia

-

-

-

 

-

Finland

199

47

152

 

199

France

16,956

9,031

7,925

 

16,956

Germany

20,785

16,738

4,047

 

20,785

Greece

2,010

1,284

726

 

2,010

Hungary

70

70

-

 

70

Iceland

-

-

-

 

-

Ireland

4,280

3,322

958

 

4,280

Italy

3,919

924

2,995

 

3,919

Latvia

-

-

-

 

-

Liechtenstein

-

-

-

 

-

Lithuania

-

-

-

 

-

Luxembourg

32

32

-

 

32

Malta

-

-

-

 

-

Netherlands

16,263

15,343

920

 

16,263

Norway

212

233

(21)

 

212

Poland

149

149

-

 

149

Portugal

660

558

102

 

660

Romania

422

422

-

 

422

Slovakia

17

17

-

 

17

Slovenia

-

-

-

 

-

Spain

821

179

642

 

821

Sweden

696

343

353

 

696

United Kingdom

19,964

16,062

3,902

 

19,964

 

 

 

 

 

 

(1) The exposures provided are for the RBS Group plc on a consolidated pro forma basis at 31 March 2010.

(2) Exposures are reported on an immediate borrower basis (e.g. an exposure of 100 to Country A, collateralised with bonds issued by Country B, is reported on Country A and not on Country B).

(3) The exposures to central and local governments include loans and receivables and securities.

(4) "Gross Exposures" are reported on the basis of their accounting value, net of impairment but gross of any Collateral and Hedging. This means:

 

- Trading, Fair value Option and AFS assets (whether securities or loans) are reported at their fair value

- Loans and receivables are reported at their amortised cost (net of impairment provisions)

- Derivatives (including credit default swaps ('CDS')) are reported at their fair value (if positive)

 

(5) "Net Exposures" are the "Gross Exposures" net of Collateral (fair-value) and Hedging (collateral and hedging between central and local administrations of the same country has not been applied).

 

Please note that the trading book exposures above are shown net of short positions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKNDQABKDCOB
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.